As we step into 2026, many pharmaceutical and med-tech teams are doing so having barely caught their breath. The past year was marked by large-scale restructures across global organisations, bringing significant internal focus, tough decisions and profound change. For many, 2025 wasn’t about acceleration – it was about resilience and reset.
The human impact of a year of restructuring
Restructures affected far more than organisational charts. Colleagues and friends lost roles, teams lost experience, and many who remained found themselves in new positions with unfamiliar responsibilities. Alongside the emotional impact came the challenge of rebuilding momentum with fewer people and less capacity.
Streamlining, productivity and AI
For many organisations, restructuring was driven by leadership decisions to streamline and improve efficiency. The rapid adoption of AI has accelerated this shift, increasing expectations around productivity and output.
For the remaining teams this has often meant:
- delivering more with less resource
- adopting AI while maintaining quality and governance
- implementing new processes at pace.
All while continuing to meet ambitious business objectives.
This article provides a helpful overview of how AI is expected to drive productivity, innovation, and new ways of working in pharma in 2026 and beyond https://eularis.com/the-future-of-ai-and-innovation-in-pharma-in-2026-and-beyond/
What teams need to succeed in leaner organisations
1. Stronger cross-functional alignment
As organisations become leaner, siloed working becomes harder to sustain. Duplication of effort, disconnected engagement with healthcare professionals (HCPs), and inconsistent use of tools and data slow progress and dilute impact. Cross-functional alignment around shared objectives, ways of working, and decision-making between medical, marketing and commercial is no longer optional. It is essential.
This article explores how breaking down silos across medical, marketing, and commercial teams can support more cohesive strategy and stronger engagement https://pmsociety.org.uk/news/the-future-of-pharmaceutical-marketing-breaking-down-barriers-for-a-cohesive-strategy/
2. Creating content that HCPs genuinely value
Alongside internal change, HCP expectations continue to evolve. There is a clear shift away from traditional promotional materials towards content that is educational, practical and problem-focused.
While technology and AI can support faster content development, HCPs are looking for support that reflects real clinical challenges and helps them solve problems for their patients. This requires insight and understanding, not just efficiency or volume.
3. Moving from multi-channel to meaningful omnichannel
Omnichannel has long been part of the industry conversation, yet the focus has often been on adding channels rather than improving relevance or coordination.
True omnichannel starts with understanding:
- what content is genuinely useful
- when it is most valuable
- how it fits into an HCP’s workflow.
This also requires teams to be aligned on how new tools and technologies are used to support engagement, rather than creating more fragmentation. Content strategy must lead channel strategy, not the other way around.
What this means for agency partnerships in 2026
These shifts are reshaping how pharma and med-tech teams work with agency partners. Leaner internal teams are increasingly looking for partners who can add strategic value, work across functions, and support cross-functional alignment.
For medical communications agencies such as Elion, this means operating as a true extension of the team, bringing insight, perspective and the ability to develop content that is relevant and meaningful to HCPs.
You can find out more about how Elion works with pharmaceutical and med-tech teams to provide strategic, insight-led medical communications support here https://elion.nz/services/
Conclusion: relevance starts with empathy
As organisations refocus in 2026, the way teams work together matters as much as what they deliver. Leaner teams need partners who understand their challenges and can help create communications that are relevant, useful and aligned.
At Elion, everything starts with empathy – listening to our clients, understanding their customers, and putting ourselves in their shoes. From there, we support teams with insight-led strategy and content that drives better engagement and outcomes.
If you’re rethinking how you work with partners in 2026 and looking for strategic medical communications support, we’d love to continue the conversation.
